-
Economic Impact of Implementing a Clinical Protocol and Therapeutic Guidelines for Cow's Milk Protein Allergy in Two States of Brazil
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States
Mar 10, 2025, 14:00 PM -
Frailty Indices Using Claims Data - Examples from a Hospitalized Medicare Population
Mar 10, 2025, 14:00 PM -
Temporal Trends in Prescription of GLP-1RAs for Weight Loss: Insights From a Five-Year Retrospective Analysis in the US
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Sociodemographic Factors on Patient Perceptions of Chronic Heart Failure Management
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns, Patient Characteristics, Healthcare Resource Utilization and Costs for Intermediate Hepatocellular Carcinoma Patients in Canada: A Retrospective Cohort Study Using Provincial Administrative Data
Mar 10, 2025, 14:00 PM -
Leveraging Artificial Intelligence to Streamline Study Quality Assessment in Systematic Literature Reviews
Mar 10, 2025, 14:00 PM -
Navigating Evidence Requirements for Joint Clinical Assessment of Orphan and Advanced Therapy Medicinal Products in Europe
Mar 10, 2025, 14:00 PM -
Patient-Reported Outcomes From a Phase 3 Study of Givinostat in Patients With Duchenne Muscular Dystrophy
Mar 10, 2025, 14:00 PM -
Burden Of Hidradenitis Suppurativa In The Brazilian Private Healthcare System
Mar 10, 2025, 14:00 PM -
Exploratory Comparison of Medication Costs Among Non-Hodgkin Lymphoma Patients With and Without Z Code Documentation
Mar 10, 2025, 14:00 PM -
Cost-Efficiency Modeling of Conversion to Biosimilar Trastuzumab-qyyp in Early-Stage Breast Cancer in Medicare
Mar 10, 2025, 14:00 PM -
Streamlined Success or Missed Opportunity: Evaluating the Impact of Simplified Economic Approaches on HTA Recommendations Across CDA-AMC, INESSS and NICE
Mar 10, 2025, 14:00 PM -
Advancing Breast Cancer Research in Japan Using EHR-Derived Real-World Data
Mar 10, 2025, 14:00 PM -
Psychometric Analysis of the EORTC QLQ-NMIBC24 Using Data from a Global Phase 2 Randomized Trial of Erdafitinib[1] in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Mar 10, 2025, 14:00 PM -
Can We Move Beyond a Best Guess? The Feasibility of Transportability Analysis to Estimate the Effect of GLP-1 Inhibitors in the Canadian Population
Mar 10, 2025, 14:00 PM -
Trends in the Prescribing and Dispensing of GLP-1 Anti-Obesity Medications Among U.S. Adults with Cardiovascular Disease and Overweight or Obesity, 2021-2024
Mar 10, 2025, 14:00 PM -
Content Validation of the NEI-VFQ-25 With Patients With Subfoveal and Non-subfoveal Geographic Atrophy: A Qualitative Study
Mar 10, 2025, 14:00 PM -
Health Utility Values of Canadian Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer
Mar 10, 2025, 14:00 PM -
Costs of Type 2 Diabetes Mellitus and Obesity in Colombian Caribbean Poor Population: A Top-Down Approach from a Cardiovascular Risk Cohort, 2020-2022
Mar 10, 2025, 14:00 PM